Goehring & Rozencwajg Associates LLC lowered its holdings in Cameco Co. (NYSE:CCJ – Free Report) (TSE:CCO) by 8.6% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 716,967 shares of the basic materials company’s stock after selling 67,849 shares during the period. Cameco comprises 7.0% of Goehring & Rozencwajg Associates LLC’s holdings, making the stock its 2nd biggest holding. Goehring & Rozencwajg Associates LLC owned about 0.16% of Cameco worth $35,275,000 as of its most recent SEC filing.
Several other hedge funds also recently made changes to their positions in the business. Bornite Capital Management LP purchased a new position in shares of Cameco in the fourth quarter worth approximately $6,590,000. Tidal Investments LLC increased its position in shares of Cameco by 15.5% in the first quarter. Tidal Investments LLC now owns 20,036 shares of the basic materials company’s stock worth $868,000 after acquiring an additional 2,683 shares in the last quarter. Eaton Financial Holdings Company LLC purchased a new position in shares of Cameco in the fourth quarter worth approximately $1,327,000. LRI Investments LLC purchased a new position in shares of Cameco in the first quarter worth approximately $30,000. Finally, Susquehanna Fundamental Investments LLC purchased a new position in shares of Cameco in the first quarter worth approximately $295,000. Institutional investors and hedge funds own 70.21% of the company’s stock.
Analyst Upgrades and Downgrades
Several research analysts have recently weighed in on the stock. Glj Research reissued a “buy” rating and issued a $63.73 target price on shares of Cameco in a research report on Wednesday, August 14th. National Bank Financial upgraded shares of Cameco to a “strong-buy” rating in a research note on Tuesday, September 3rd. Scotiabank reduced their target price on shares of Cameco from $81.00 to $80.00 and set an “outperform” rating for the company in a research note on Monday, August 19th. Cantor Fitzgerald upgraded shares of Cameco from a “neutral” rating to an “overweight” rating in a research note on Wednesday, July 31st. Finally, Bank of America lifted their target price on shares of Cameco from $59.00 to $60.50 and gave the company a “buy” rating in a research note on Wednesday, June 26th. One research analyst has rated the stock with a sell rating, five have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of $67.25.
Cameco Price Performance
Shares of Cameco stock opened at $40.12 on Thursday. The firm has a fifty day simple moving average of $42.18 and a 200-day simple moving average of $46.49. The company has a current ratio of 3.22, a quick ratio of 1.48 and a debt-to-equity ratio of 0.23. Cameco Co. has a 1-year low of $35.18 and a 1-year high of $56.24. The stock has a market capitalization of $17.46 billion, a price-to-earnings ratio of 102.87 and a beta of 0.90.
Cameco (NYSE:CCJ – Get Free Report) (TSE:CCO) last issued its quarterly earnings data on Wednesday, July 31st. The basic materials company reported $0.14 earnings per share for the quarter, missing analysts’ consensus estimates of $0.28 by ($0.14). Cameco had a return on equity of 5.63% and a net margin of 9.72%. The firm had revenue of $598.00 million during the quarter, compared to analyst estimates of $756.00 million. During the same quarter in the previous year, the firm posted ($0.01) earnings per share. Cameco’s quarterly revenue was up 24.1% compared to the same quarter last year. On average, sell-side analysts expect that Cameco Co. will post 0.96 earnings per share for the current year.
Cameco Company Profile
Cameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.
Read More
- Five stocks we like better than Cameco
- Differences Between Momentum Investing and Long Term Investing
- Why General Mills Is the Perfect Hedge for S&P 500 Volatility
- What is a Special Dividend?
- Viking Therapeutics Is Having a Year to Remember: Time to Buy?
- 3 REITs to Buy and Hold for the Long Term
- Leverage Proven Stock Factors With These Top 3 Smart Beta ETFs
Receive News & Ratings for Cameco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cameco and related companies with MarketBeat.com's FREE daily email newsletter.